275 related articles for article (PubMed ID: 26420962)
1. TP53 codon 72 Arg/Arg polymorphism is associated with a higher risk for inflammatory bowel disease development.
Volodko N; Salla M; Eksteen B; Fedorak RN; Huynh HQ; Baksh S
World J Gastroenterol; 2015 Sep; 21(36):10358-66. PubMed ID: 26420962
[TBL] [Abstract][Full Text] [Related]
2. TP53 Gene 72 Arg/Pro (rs1042522) Single Nucleotide Polymorphism Contribute to Increase the Risk of B-Chronic Lymphocytic Leukemia in the Sudanese Population.
Mohammed Basabaeen AA; Abdelgader EA; Babekir EA; Abdelrahim SO; Eltayeb NH; Altayeb OA; Fadul EA; Sabo A; Ibrahim IK
Asian Pac J Cancer Prev; 2019 May; 20(5):1579-1585. PubMed ID: 31128065
[TBL] [Abstract][Full Text] [Related]
3. R72P polymorphism of TP53 in ulcerative colitis patients is associated with the incidence of colectomy, use of steroids and the presence of a positive family history.
Eren F; Akkiprik M; Atuğ O; Sönmez O; Tahan G; Ozdemir F; Hamzaoğlu HO; Celikel CA; Imeryüz N; Avşar E; Ozer A
Pathol Oncol Res; 2010 Dec; 16(4):563-8. PubMed ID: 20309662
[TBL] [Abstract][Full Text] [Related]
4. Fuzzy clustering demonstrates that codon 72 SNP rs1042522 of TP53 gene associated with HNSCC but not with prognoses.
Pinheiro UB; Fraga CA; Mendes DC; Farias LC; Cardoso CM; Silveira CM; D'Angelo MF; Jones KM; Santos SH; de Paula AM; Guimarães AL
Tumour Biol; 2015 Dec; 36(12):9259-65. PubMed ID: 26099726
[TBL] [Abstract][Full Text] [Related]
5. TP53 polymorphisms in gliomas from Indian patients: Study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3.
Jha P; Jha P; Pathak P; Chosdol K; Suri V; Sharma MC; Kumar G; Singh M; Mahapatra AK; Sarkar C
Exp Mol Pathol; 2011 Apr; 90(2):167-72. PubMed ID: 21115003
[TBL] [Abstract][Full Text] [Related]
6. Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women.
Jiang P; Liu J; Zeng X; Li W; Tang J
Cancer Genet Cytogenet; 2010 Mar; 197(2):174-8. PubMed ID: 20193851
[TBL] [Abstract][Full Text] [Related]
7. TP53 codon 72 polymorphism and P53 protein expression in colorectal cancer specimens in Isfahan.
Dastjerdi MN
Acta Med Iran; 2011; 49(2):71-7. PubMed ID: 21598212
[TBL] [Abstract][Full Text] [Related]
8. TP53 codon 72 polymorphism and breast cancer risk in Bangladeshi population.
Hossain A; Murshid GMM; Zilani MNH; Islam F; Sultana R; Sultana T; Hossain MG; Rahman MM
Breast Cancer; 2017 Jul; 24(4):571-578. PubMed ID: 27837441
[TBL] [Abstract][Full Text] [Related]
9. The TP53 codon 72 polymorphism and predisposition to adrenocortical cancer in Polish patients.
Ignaszak-Szczepaniak M; Horst-Sikorska W; Sawicka J; Kaczmarek M; Slomski R
Oncol Rep; 2006 Jul; 16(1):65-71. PubMed ID: 16786124
[TBL] [Abstract][Full Text] [Related]
10. TP53 codon 72 polymorphism is associated with pancreatic cancer risk in males, smokers and drinkers.
Sonoyama T; Sakai A; Mita Y; Yasuda Y; Kawamoto H; Yagi T; Yoshioka M; Mimura T; Nakachi K; Ouchida M; Yamamoto K; Shimizu K
Mol Med Rep; 2011; 4(3):489-95. PubMed ID: 21468597
[TBL] [Abstract][Full Text] [Related]
11. Study on TP53 codon 72 polymorphisms with oral carcinoma susceptibility.
Zhuo XL; Li Q; Zhou Y; Cai L; Xiang ZL; Yuan W; Zhang XY
Arch Med Res; 2009 Oct; 40(7):625-34. PubMed ID: 20082880
[TBL] [Abstract][Full Text] [Related]
12. Association of TP53 codon 72 and CDH1 genetic polymorphisms with colorectal cancer risk in Bangladeshi population.
Rivu SF; Apu MNH; Shabnaz S; Nahid NA; Islam MR; Al-Mamun MMA; Nahar Z; Rabbi SNI; Ahmed MU; Islam MS; Hasnat A
Cancer Epidemiol; 2017 Aug; 49():46-52. PubMed ID: 28554075
[TBL] [Abstract][Full Text] [Related]
13. Arginine homozygosity in codon 72 of p53 correlates with failure to imatinib response in chronic myeloid leukemia.
Camelo-Santos J; do Prado Barbosa A; de Paula Silveira-Lacerda E; Guillo LA
Biomed Pharmacother; 2013 Mar; 67(2):103-7. PubMed ID: 23433851
[TBL] [Abstract][Full Text] [Related]
14. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
[TBL] [Abstract][Full Text] [Related]
15. TP53 genetic polymorphisms and susceptibility to cervical cancer in Bangladeshi women: a case-control study.
Apu MNH; Rashed AZM; Bashar T; Rahman MM; Mostaid MS
Mol Biol Rep; 2020 Jun; 47(6):4357-4364. PubMed ID: 32424519
[TBL] [Abstract][Full Text] [Related]
16. TP53 (rs1042522, rs28934571) and TP21 (rs1801270, rs1059234) Polymorphisms and Risk of Breast Cancer among Rural Women of Maharashtra: Findings from a Hospital Based Case- Control Study.
Datkhile KD; Bhosale SJ; Durgawale PP; Jagdale NJ; More AL; Gudur RA; Gudur AK; Patil SR
Asian Pac J Cancer Prev; 2023 May; 24(5):1611-1619. PubMed ID: 37247280
[TBL] [Abstract][Full Text] [Related]
17. TP53 gene polymorphisms at codons 11, 72, and 248 and association with endometriosis in a Brazilian population.
Camargo-Kosugi CM; D'Amora P; Kleine JP; Carvalho CV; Sato H; Schor E; Silva ID
Genet Mol Res; 2014 Aug; 13(3):6503-11. PubMed ID: 25177931
[TBL] [Abstract][Full Text] [Related]
18. Significant association of TP53 Arg72Pro polymorphism in susceptibility to differentiated thyroid cancer.
Khan MS; Pandith AA; Masoodi SR; Khan SH; Rather TA; Andrabi KI; Mudassar S
Cancer Biomark; 2015; 15(4):459-65. PubMed ID: 25835179
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population.
Mostaid MS; Ahmed MU; Islam MS; Bin Sayeed MS; Hasnat A
Tumour Biol; 2014 Oct; 35(10):10309-17. PubMed ID: 25034526
[TBL] [Abstract][Full Text] [Related]
20. Impact of TP53 codon 72 and MDM2 SNP 309 polymorphisms in pancreatic ductal adenocarcinoma.
Hori Y; Miyabe K; Yoshida M; Nakazawa T; Hayashi K; Naitoh I; Shimizu S; Kondo H; Nishi Y; Umemura S; Kato A; Ohara H; Inagaki H; Joh T
PLoS One; 2015; 10(3):e0118829. PubMed ID: 25734904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
